InsiderTrades

Form 4 for BIIB Biogen

Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-06 · accession 0001127602-25-003958 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-10 2025-02-07 BIIB Kramer Robin CAO F - Tax $141.35 -476 7,423 -6% -$67.3K
DM 2025-02-10 2025-02-07 BIIB Kramer Robin CAO M - OptEx $0.00 +1,491 7,667 +24% $0
DM 2025-02-10 2025-02-07 BIIB Kramer Robin CAO M - OptEx $0.00 -1,491 1,407 -51% $0
D 2025-02-10 2025-02-06 BIIB Kramer Robin CAO A - Grant $0.00 +10.5K 10.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-07 F D 232 $141.35 6,963.75 D — —
2 Common Common Stock 2025-02-07 M A 788 $0.00 7,195.75 D — —
3 Common Common Stock 2025-02-07 F D 244 $141.35 7,422.75 D — —
4 Common Common Stock 2025-02-07 M A 703 $0.00 7,666.75 D — —
5 Derivative Restricted Stock Unit 2025-02-07 M D 788 $0.00 789 D $0.00 · — to 2026-02-08 788 Common Stock (F2) The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.
6 Derivative Restricted Stock Unit 2025-02-07 M D 703 $0.00 1,407 D $0.00 · — to 2027-02-07 703 Common Stock (F3) The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
7 Derivative Restricted Stock Unit 2025-02-06 A A 10,535 $0.00 10,535 D $0.00 · — to 2025-02-06 10,535 Common Stock (F1) The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.